Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

106.21
Delayed Data
As of Apr 29
 -1.04 / -0.97%
Today’s Change
61.38
Today|||52-Week Range
112.00
+34.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line293.2M391.7M811.1M494.9M
 
 
 
 
 
Depreciation57.3M68.7M68.6M65.8M
 
 
 
 
 
Total Other Cash Flow3.7M-9.3M23.4M19.6M
 
 
 
 
 
Funds From Operations362.3M451.2M832.0M485.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-11.5M-21.5M-190.3M-64.4M
 
 
 
 
 
Net Cash Flow - Operating Activities373.8M472.7M1.0B549.7M
 
 
 
 
 
 
InvestingIncrease In Investments-595.2M-827.6M-2.1B-1.3B
 
 
 
 
 
Decrease In Investments665.1M526.7M1.6B1.4B
 
 
 
 
 
Capital Expenditures-120.7M-109.0M-82.9M-102.7M
 
 
 
 
 
Fixed Asset Disposal3.0M2.3M3.1M2.4M
 
 
 
 
 
Net Assets From Acquisitions -36.6M0.00-15.0M-331.6M
 
 
 
 
Other Investing - Uses0.00-4.0M-10.8M0.00
 
 
 
Other Investing - Sources900.0K--0.00--
 
 
Net Cash Flow Investing-90.5M-412.7M-633.0M-316.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings407.0M1.3B226.3M31.4M
 
 
 
 
 
Long Term Debt Reduction-367.5M-895.4M-239.0M-29.5M
 
 
 
 
 
Net Proceeds Stock Sale100.1M45.5M113.3M87.2M
 
 
 
 
 
Common Preferred Redeemed-344.1M-496.9M-300.9M-280.1M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing58.0M76.7M49.4M41.3M
 
 
 
 
 
Other Uses - Financing9.1M0.002.1M8.9M
 
 
 
 
Net Cash Flow - Financing-155.6M34.9M-153.0M-158.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash12.0M14.6M-2.9M-10.4M
 
 
 
 
 
 
Net Change In Cash127.7M94.9M236.3M75.0M